Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

46.84
+0.17000.36%
Post-market: 46.850.0081+0.02%19:59 EDT
Volume:17.15M
Turnover:802.65M
Market Cap:67.88B
PE:18.98
High:47.22
Open:46.85
Low:46.50
Close:46.67
52wk High:109.50
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.67
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.72
PE(LYR):24.14

Loading ...

Boston Scientific FY26 Q2 Net Income Rises 13.8% to 907 Million; Net Sales Climb 7.5% to 5.44 Billion

Reuters
·
Aug 03

Why Boston Scientific (BSX) Is Up 5.6% After Mixed Q2, Recall News And Guidance Update

Simply Wall St.
·
Aug 02

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 01

Movement Alert|Boston Scientific Falls 3.13% in Regular Trading, Argus Downgrades Rating to Hold Extending Post-Earnings Selling Pressure

Market Focus
·
Jul 31

Argus Downgrades Boston Scientific to Hold From Buy

MT Newswires Live
·
Jul 31

Boston Scientific Cut to Hold from Buy by Argus Research

Dow Jones
·
Jul 31

Boston Scientific Corp : Argus Research Cuts to Hold from Buy

THOMSON REUTERS
·
Jul 31

Boston Scientific (BSX) Stock Ignores Margin Strength As Growth Outlook Softens

Simply Wall St.
·
Jul 31

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Penumbra Q2 FY26 Net Income Falls to 34.81 Million; Revenue Rises 14.9% to 390 Million

Reuters
·
Jul 31

Penumbra Q2 Revenue Slightly Beats Estimates, Helped by Product Segment Increase

Reuters
·
Jul 31

Cerus Q2 Adjusted Ebitda Misses Estimates, Raises 2026 Outlook

Reuters
·
Jul 31

Penumbra - Will not Provide Full Year 2026 Guidance or Host Conference Call Due to Pending Acquisition

THOMSON REUTERS
·
Jul 31

Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says

MT Newswires Live
·
Jul 31

Boston Scientific Lowered Full-Year Guidance on Headwinds in Electrophysiology, Watchman Portfolios, RBC Says

MT Newswires Live
·
Jul 30

Movement Alert|Boston Scientific Falls 3.06% in Regular Trading, Multiple Banks Cut Price Targets Post-Earnings on Watchman Weakness

Market Focus
·
Jul 30

UBS Adjusts Boston Scientific Price Target to $67 From $74, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Deutsche Bank Adjusts Boston Scientific PT to $60 From $75, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Baxter Q2 Revenue Rises 5%, Beats Analyst Estimates

Reuters
·
Jul 30

Boston Scientific Corp : TD Cowen Cuts Target Price to $56 from $61

THOMSON REUTERS
·
Jul 30